Search Results - "Plog, Malinda"

Enhanced efficacy of melanoma vaccines in the absence of B lymphocytes by PERRICONE, Michael A, SMITH, Karen A, CLAUSSEN, Kirsten A, PLOG, Malinda S, HEMPEL, Donna M, ROBERTS, Bruce L, ST. GEORGE, Judith A, KAPLAN, Johanne M

“…Provoking a specific cellular immune response against tumor-associated antigens is a promising therapeutic strategy to treat cancers with defined antigens such…”
Get full text

Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery by Plog, Malinda S, Guyre, Cheryl A, Roberts, Bruce L, Goldberg, Mark, St George, Judith A, Perricone, Michael A

“…The recombinant adenoviral (Ad) vector is being considered as a cancer vaccine platform because it efficiently induces immune responses to tumor antigens by…”
Get more information

Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium by Perricone, M A, Morris, J E, Pavelka, K, Plog, M S, O'Sullivan, B P, Joseph, P M, Dorkin, H, Lapey, A, Balfour, R, Meeker, D P, Smith, A E, Wadsworth, S C, St George, J A

“…A phase I clinical trial was conducted in which recombinant adenovirus containing the cystic fibrosis trans-membrane regulator (CFTR) (Ad2/CFTR) was…”
Get more information

Adenoviral Vector Expressing ICP47 Inhibits Adenovirus-Specific Cytotoxic T Lymphocytes in Nonhuman Primates by Scaria, Abraham, Sullivan, Jennifer A., St. George, Judith A., Kaplan, Johanne M., Lukason, Michael J., Morris, James E., Plog, Malinda, Nicolette, Charles, Gregory, Richard J., Wadsworth, Samuel C.

“…Studies from several laboratories have shown that administration of E1-deleted Ad vectors results only in transient transgene expression in the lungs of…”
Get full text